文献速递肿瘤 PET/CT神经核医学

神经母细胞瘤检测:[64Cu]GD2 PET与[123I]MIBG SPECT的头对头比较

Head-to-Head Comparison of Neuroblastoma Detection by [64Cu]GD2 PET and [123I]MIBG SPECT.
PubMed 文献 · J Nucl Med · 2026-09-30

该研究对5例神经母细胞瘤患者行[123I]MIBG SPECT、[64Cu]GD2 PET及MRI检查,用SIOPEN和改良Curie评分比较两种分子影像的病灶检出。两种方法均检出全部患者病灶,但[64Cu]GD2 PET在多发转移患者中检出额外病灶并致评分更高,提示其用于神经母细胞瘤转移检测的可行性。

要点

  • 5例神经母细胞瘤患者中,[64Cu]GD2 PET与[123I]MIBG SPECT均检出病灶。
  • 多发转移患者中[64Cu]GD2 PET检出额外病灶,SIOPEN和改良Curie评分更高。
  • 初步数据提示[64Cu]GD2 PET适用于神经母细胞瘤转移检测。

核心结论

  • 初步数据提示[64Cu]GD2 PET可用于神经母细胞瘤转移灶的检测。

研究设计与样本

  • 5例神经母细胞瘤患者接受[123I]MIBG SPECT、[64Cu]GD2 PET和MRI检查。
  • 采用SIOPEN和改良Curie评分比较[123I]MIBG与[64Cu]GD2检出的病灶。

主要发现

  • 3例患者为多发转移,2例为孤立淋巴结转移。
  • 两种方法在每例患者中均检出病灶。
  • 多发转移患者中[64Cu]GD2较[123I]MIBG检出额外病灶,SIOPEN和改良Curie评分更高。

临床怎么用

  • 在GD2靶向治疗相关评估中,可考虑用[64Cu]GD2 PET无创检测GD2表达及转移灶。

局限性

  • 本研究为仅5例患者的初步头对头比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

123I-labeled metaiodobenzylguanidine ([123I]MIBG) SPECT is well-established for neuroblastoma diagnostics. Nevertheless, therapies targeting GD2 on neuroblastoma gain clinical importance in standard treatment and clinical trials, which emphasizes the relevance of PET using the radiolabeled GD2 antibody [64Cu]Cu-NOTA-ch14.18/CHO ([64Cu]GD2) for noninvasive detection of GD2 expression. Here, we present an initial comparison of the diagnostic performance of [64Cu]GD2 PET and [123I]MIBG SPECT. Methods: Five patients with neuroblastoma underwent [123I]MIBG SPECT, [64Cu]GD2 PET, and MRI. The detected lesions were compared between [123I]MIBG and [64Cu]GD2 using International Society of Pediatric Oncology Europe Neuroblastoma (SIOPEN) and modified Curie scores. Results: Three patients suffered from multiple metastases, and 2 patients presented solitary lymph node metastases. Both modalities detected lesions in every patient; [64Cu]GD2 revealed additional lesions in patients with multiple metastases compared with [123I]MIBG, leading to higher SIOPEN and modified Curie scores. Conclusion: These initial data indicate the diagnostic suitability of [64Cu]GD2 for detection of neuroblastoma metastasis.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Trautwein NF, Spogis J, Reischl G, et al. Head-to-Head Comparison of Neuroblastoma Detection by [64Cu]GD2 PET and [123I]MIBG SPECT. J Nucl Med. 2026. PMID: 42816124. doi:10.2967/jnumed.126.272350

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。